28 studies found for:    " April 13, 2011":" May 13, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth
Conditions: Patient Adherence;   HIV
Intervention: Behavioral: SMS Text Message Reminder
2 Recruiting Treatment Advocacy Intervention for HIV-Positive African Americans
Condition: HIV
Intervention: Behavioral: Treatment Advocacy
3 Active, not recruiting Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: EVG/COBI/FTC/TDF;   Drug: COBI;   Drug: ATV;   Drug: DRV;   Drug: NRTI
4 Recruiting Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
Conditions: Hepatitis;   HIV;   Liver Cancer
Intervention:
5 Active, not recruiting Switch to Unboosted Atazanavir With Tenofovir Study
Condition: HIV Infection
Interventions: Drug: atazanavir;   Drug: atazanavir/ritonavir
6 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
7 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
8 Completed Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users
Condition: HIV Infections
Interventions: Behavioral: Text messaging plus EMA;   Behavioral: Treatment as usual
9 Terminated Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
Condition: HIV Disease
Interventions: Drug: HAART regimen;   Drug: 3TC or FTC monotherapy
10 Recruiting Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS
Condition: HIV Infections
Intervention: Drug: "Kallunk oxide (Immunotherapy) "
11 Completed Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
Conditions: Neurocognitive Disturbance;   HIV Infection
Interventions: Drug: Lithium;   Drug: Rivastigmine
12 Recruiting Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients
Conditions: HIV-1 Infection;   AIDS
Interventions: Drug: Maraviroc (Celsentri);   Drug: Placebo
13 Completed Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023
Condition: Human Immunodeficiency Virus
Interventions: Drug: KM-023;   Drug: Placebo for KM-023
14 Completed Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus
Condition: HIV-1 Infection
Interventions: Drug: Cenicriviroc 100 mg;   Drug: Cenicriviroc 200 mg + Truvada;   Drug: Sustiva + Truvada
15 Not yet recruiting Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection
Condition: HIV
Interventions: Drug: atripla;   Drug: darunavir ritonavir raltegravir
16 Recruiting Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Condition: HIV
Interventions: Drug: Atazanavir Sulphate;   Drug: Ritonavir
17 Active, not recruiting Human Immune Responses Toward HIV-1 Envelope Antigens
Condition: HIV Infection
Intervention:
18 Active, not recruiting Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China
Conditions: HIV Infections;   Central Nervous System Diseases;   Dementia
Interventions: Drug: zidovudine-lamivudine-nevirapine;   Drug: tenofovir-lamivudine-efavirenz
19 Completed Drug Drug Interaction of BI 201335 and Tenofovir
Condition: HIV Infections
Intervention: Drug: tenofovir/BI 201335
20 Terminated Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003)
Condition: HIV-1 Infection
Interventions: Drug: MK-1972;   Drug: Placebo to MK-1972

Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results
Indicates status has not been verified in more than two years